Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease
- PMID: 12700346
- DOI: 10.1194/jlr.M300121-JLR200
Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease
Abstract
Adult Refsum disease (ARD) is associated with defective alpha-oxidation of phytanic acid (PA). omega-Oxidation of PA to 3-methyl-adipic acid (3-MAA) occurs although its clinical significance is unclear. In a 40 day study of a new ARD patient, where the plasma half-life of PA was 22.4 days, omega-oxidation accounted for 30% initially and later all PA excretion. Plasma and adipose tissue PA and 3-MAA excretion were measured in a cross-sectional study of 11 patients. The capacity of the omega-oxidation pathway was 6.9 (2.8-19.4) mg [20.4 (8.3-57.4) micromol] PA/day. 3-MAA excretion correlated with plasma PA levels (r = 0.61; P = 0.03) but not adipose tissue PA content. omega-Oxidation during a 56 h fast was studied in five patients. 3-MAA excretion increased by 208 +/- 58% in parallel with the 158 (125-603)% rise in plasma PA. Plasma PA doubled every 29 h, while 3-MAA excretion followed second-order kinetics. Acute sequelae of ARD were noted in three patients (60%) after fasting. The omega-oxidation pathway can metabolise PA ingested by patients with ARD, but this activity is dependent on plasma PA concentration. omega-Oxidation forms a functional reserve capacity that enables patients with ARD undergoing acute stress to cope with limited increases in plasma PA levels.
Similar articles
-
Metabolism of phytanic acid in Refsum's disease.Lancet. 1982 Jan 23;1(8265):194-6. doi: 10.1016/s0140-6736(82)90760-7. Lancet. 1982. PMID: 6172683 No abstract available.
-
2,6-Dimethyloctanedioic acid--a metabolite of phytanic acid in Refsum's disease.Clin Chem. 1983 Mar;29(3):434-7. Clin Chem. 1983. PMID: 6186413
-
Omega-hydroxylation of phytanic acid in rat liver microsomes: implications for Refsum disease.J Lipid Res. 2004 Jul;45(7):1341-6. doi: 10.1194/jlr.M400064-JLR200. Epub 2004 Apr 21. J Lipid Res. 2004. PMID: 15102880
-
Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.Biochem Soc Trans. 2007 Nov;35(Pt 5):865-9. doi: 10.1042/BST0350865. Biochem Soc Trans. 2007. PMID: 17956234 Review.
-
Refsum disease, peroxisomes and phytanic acid oxidation: a review.J Neuropathol Exp Neurol. 2001 Nov;60(11):1021-31. doi: 10.1093/jnen/60.11.1021. J Neuropathol Exp Neurol. 2001. PMID: 11706932 Review.
Cited by
-
Pregnancy outcome in Refsum disease: Affected fetuses and children born to an affected mother.JIMD Rep. 2019 Mar 14;46(1):11-15. doi: 10.1002/jmd2.12020. eCollection 2019 Mar. JIMD Rep. 2019. PMID: 31240149 Free PMC article.
-
The biochemistry and physiology of long-chain dicarboxylic acid metabolism.Biochem J. 2023 May 15;480(9):607-627. doi: 10.1042/BCJ20230041. Biochem J. 2023. PMID: 37140888 Free PMC article. Review.
-
Tissue Proteome of 2-Hydroxyacyl-CoA Lyase Deficient Mice Reveals Peroxisome Proliferation and Activation of ω-Oxidation.Int J Mol Sci. 2022 Jan 17;23(2):987. doi: 10.3390/ijms23020987. Int J Mol Sci. 2022. PMID: 35055171 Free PMC article.
-
Fibroblast-specific genome-scale modelling predicts an imbalance in amino acid metabolism in Refsum disease.FEBS J. 2020 Dec;287(23):5096-5113. doi: 10.1111/febs.15292. Epub 2020 Mar 31. FEBS J. 2020. PMID: 32160399 Free PMC article.
-
The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage.Molecules. 2022 Dec 8;27(24):8691. doi: 10.3390/molecules27248691. Molecules. 2022. PMID: 36557825 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
